Startseite/Aktien/XCUR

XCUR

USD

Exicure Inc. Common Stock

$10.800-0.632 (-5.526%)

Echtzeitkurs

Healthcare

Biotechnologie

Vereinigte Staaten

Kursdiagramm

Schlüsselkennzahlen

Marktkennzahlen

Unternehmensfundamentaldaten

Handelsstatistiken

Marktkennzahlen

Eröffnung

$11.432

Hoch

$11.607

Tief

$10.800

Volumen

0.00M

Unternehmensfundamentaldaten

Marktkapitalisierung

70.3M

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.03M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.44Aktuell $10.800Hoch $36

Ähnliche Nachrichten

14. Apr. 2025 · 22:11

BusinessWire

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

Exicure, Inc. (NASDAQ:XCUR) today announced that GPCR Therapeutics USA, a subsidiary of Exicure Inc., has dosed the 19th patient in its ongoing Phase 2 clinical trial evaluating GPC-100 (burixafor), a small molecule

Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma

11. Apr. 2025 · 23:42

BusinessWire

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

Exicure, Inc. (NASDAQ:XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid Leukemia (AML) with